Position in ZYME
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,855,940
-$22,060 QoQ
Shares Held
71,000
-5.3% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 202 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CREDIT AGRICOLE S A holds $155,130,924 across 28 Biotechnology names. ZYME ranks #12 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
115,955 | $57,598,325 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,977 | $24,303,717 | |
| 3 | MRNA |
Moderna, Inc.
|
235,537 | $16,494,654 | |
| 4 | INCY |
Incyte Corp
|
77,484 | $8,783,585 | |
| 5 | RPRX |
Royalty Pharma plc
|
142,595 | $7,995,301 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
26,000 | $6,265,220 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
12,976 | $4,822,789 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
85,930 | $4,686,622 |
All Filings in ZYME
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,855,940 | 71,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,878,000 | 75,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,974,750 | 75,000 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $893,250 | 75,000 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,098,000 | 75,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,413 | 75,000 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||